Literature DB >> 21890785

Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study.

Virender S Sangwan1, Sayan Basu, Geeta K Vemuganti, Kunjal Sejpal, Sandhya V Subramaniam, Souvik Bandyopadhyay, Sannapaneni Krishnaiah, Subhash Gaddipati, Shubha Tiwari, Dorairajan Balasubramanian.   

Abstract

PURPOSE: Ocular burns can damage the corneal epithelial stem cells located at the limbus. This study evaluated the efficacy of xeno-free autologous cell-based treatment of limbal stem cell deficiency.
METHODS: This retrospective study included 200 patients, above 8 years of age, with clinically diagnosed unilateral total limbal stem cell deficiency due to ocular surface burns treated between 2001 and 2010. A small limbal biopsy was obtained from the unaffected eye. The limbal epithelial cells were expanded ex vivo on human amniotic membrane for 10-14 days using a xeno-free explant culture system. The resulting cultured epithelial monolayer and amniotic membrane substrate were transplanted on to the patient's affected eye. Postoperative corneal surface stability, visual improvement and complications were objectively analysed.
RESULTS: A completely epithelised, avascular and clinically stable corneal surface was seen in 142 of 200 (71%) eyes at a mean follow-up of 3 ± 1.6 (range: 1-7.6) years. A two-line improvement in visual acuity, without further surgical intervention, was seen in 60.5% of eyes. All donor eyes remained healthy.
CONCLUSIONS: Autologous cultivated limbal epithelial transplantation using a xeno-free explant culture technique was effective in long-term restoration of corneal epithelial stability and improvement of vision in eyes with ocular surface burns.

Entities:  

Mesh:

Year:  2011        PMID: 21890785     DOI: 10.1136/bjophthalmol-2011-300352

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  85 in total

1.  [Long-term results of autologous transplantation of limbal epithelium cultivated ex vivo for limbal stem cell deficiency].

Authors:  S L Scholz; H Thomasen; K Hestermann; D Dekowski; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2016-04       Impact factor: 1.059

Review 2.  Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.

Authors:  Qihua Le; Tulika Chauhan; Madeline Yung; Chi-Hong Tseng; Sophie X Deng
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

Review 3.  Concise review: identifying limbal stem cells: classical concepts and new challenges.

Authors:  Aaron W Joe; Sonia N Yeung
Journal:  Stem Cells Transl Med       Date:  2013-12-10       Impact factor: 6.940

4.  Suitability of human Tenon's fibroblasts as feeder cells for culturing human limbal epithelial stem cells.

Authors:  Gaia Scafetta; Eleonora Tricoli; Camilla Siciliano; Chiara Napoletano; Rosa Puca; Enzo Maria Vingolo; Giuseppe Cavallaro; Andrea Polistena; Giacomo Frati; Elena De Falco
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

5.  Optimal isolation and xeno-free culture conditions for limbal stem cell function.

Authors:  Kalliopi Stasi; DaVida Goings; Jiayan Huang; Lindsay Herman; Filipa Pinto; Russell C Addis; Dahlia Klein; Giacomina Massaro-Giordano; John D Gearhart
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-20       Impact factor: 4.799

6.  Next-generation stem cell therapy poised to enter EU market.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

7.  Systematic review and meta-analysis investigating autograft versus allograft cultivated limbal epithelial transplantation in limbal stem cell deficiency.

Authors:  Mohammad Amir Mishan; Mehdi Yaseri; Alireza Baradaran-Rafii; Mozhgan Rezaei Kanavi
Journal:  Int Ophthalmol       Date:  2019-03-02       Impact factor: 2.031

8.  Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells.

Authors:  Heidi Hongisto; Meri Vattulainen; Tanja Ilmarinen; Alexandra Mikhailova; Heli Skottman
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

Review 9.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

10.  ROCK inhibitor Y-27632 increases the cloning efficiency of limbal stem/progenitor cells by improving their adherence and ROS-scavenging capacity.

Authors:  Qingjun Zhou; Haoyun Duan; Yao Wang; Mingli Qu; Lingling Yang; Lixin Xie
Journal:  Tissue Eng Part C Methods       Date:  2012-12-28       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.